Aptevo Biotherapeutics Llc opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Aptevo Biotherapeutics Llc

Patent Number:
Title:
Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein Expression
Applicant:
Opposition Date:
Jun 18, 2018

Competitors of Aptevo Biotherapeutics Llc

BAXALTA GMBH

BAXALTA INCORPORATED

BAXTER HEALTHCARE S.A.

Want to track Aptevo Biotherapeutics Llc?

Feel free to send us a message here and we will get back to you